MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue

Journal of Molecular Diagnostics

Volumn 16, Issue 2, 2014, Pages 190-197

  Sapino, Anna ^a   Roepman, Paul ^b   Linn, Sabine C ^c,d   Snel, Mireille H J ^b   Delahaye, Leonie J M J ^b   Van Den Akker, Jeroen ^b   Glas, Annuska M ^b   Simon, Iris M ^b   Barth, Neil ^e   De Snoo, Femke A ^b   Van 'T Veer, Laura J ^b   Molinaro, Luca ^a   Berns, Els M J J ^f   Wesseling, Jelle ^c   Riley, Lee B ^g   Anderson, David ^g   Nguyen, Bichlien ^h   Cox, Charles E ⁱ  

^a UNIVERSITY OF TURIN   (Italy)

^b Agendia NV   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Agendia Inc   (United States)

^f ERASMUS MC CANCER INSTITUTE   (Netherlands)

^g ST LUKE S HOSPITAL   (United States)

^h LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY DETECTION OF CANCER; FORMALDEHYDE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; PARAFFIN EMBEDDING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION;

EID: 84894033527     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.10.008     Document Type: Article

References (32)

1. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, and S.H. Friend Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
2. M.J. van de Vijver, Y.D. He, L.J. van't Veer, H. Dai, A.A. Hart, D.W. Voskuil, G.J. Schreiber, J.L. Peterse, C. Roberts, M.J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E.T. Rutgers, S.H. Friend, and R. Bernards A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
3. M. Buyse, S. Loi, van't Veer L, G. Viale, M. Delorenzi, A.M. Glas, M.S. d'Assignies, J. Bergh, R. Lidereau, P. Ellis, A. Harris, J. Bogaerts, P. Therasse, A. Floore, M. Amakrane, F. Piette, E. Rutgers, C. Sotiriou, F. Cardoso, M.J. Piccart TRANSBIG Consortium Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 98 2006 1183 1192
4. B.S. Wittner, D.C. Sgroi, P.D. Ryan, T.J. Bruinsma, A.M. Glas, A. Male, S. Dahiya, K. Habin, R. Bernards, D.A. Haber, L.J. van't Veer, and S. Ramaswamy Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort Clin Cancer Res 14 2008 2988 2993
5. S. Mook, M.K. Schmidt, G. Viale, G. Pruneri, I. Eekhout, A. Floore, A.M. Glas, J. Bogaerts, F. Cardoso, M.J. Piccart-Gebhart, E.T. Rutgers, L.J. van't Veer TRANSBIG Consortium The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study Breast Cancer Res Treat 116 2009 295 302
6. J.M. Bueno-de-Mesquita, S.C. Linn, R. Keijzer, J. Wesseling, D.S. Nuyten, C. van Krimpen, C. Meijers, P.W. de Graaf, M.M. Bos, A.A. Hart, E.J. Rutgers, J.L. Peterse, H. Halfwerk, R. de Groot, A. Pronk, A.N. Floore, A.M. Glas, L.J. van't Veer, and M.J. van de Vijver Validation of 70-gene prognosis signature in node-negative breast cancer Breast Cancer Res Treat 117 2009 483 495
7. S. Mook, M.K. Schmidt, B. Weigelt, B. Kreike, I. Eekhout, M.J. van de Vijver, A.M. Glas, A. Floore, E.J. Rutgers, and L.J. van 't Veer The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age Ann Oncol 21 2010 717 722
8. S. Mook, M. Knauer, J.M. Bueno-de-Mesquita, V.P. Retel, J. Wesseling, S.C. Linn, L.J. van't Veer, and E.J. Rutgers Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature Ann Surg Oncol 17 2010 1406 1413
9. M. Ishitobi, T.E. Goranova, Y. Komoike, K. Motomura, H. Koyama, A.M. Glas, E. van Lienen, H. Inaji, L.J. van't Veer, and K. Kato Clinical utility of the 70-gene MammaPrint profile in a Japanese population Jpn J Clin Oncol 40 2010 508 512
10. M. Saghatchian, S. Mook, G. Pruneri, G. Viale, A.M. Glas, S. Guerin, F. Cardoso, M. Piccart, T. Tursz, S. Delaloge, and L. van't Veer Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes Breast 22 2013 682 5690
11. L.J. Esserman, D.A. Berry, M.C. Cheang, C. Yau, C.M. Perou, L. Carey, A. Demichele, J.W. Gray, K. Conway-Dorsey, M.E. Lenburg, M.B. Buxton, S.E. Davis, L.J. van't Veer, C. Hudis, K. Chin, D. Wolf, H. Krontiras, L. Montgomery, D. Tripathy, C. Lehman, M.C. Liu, O.I. Olopade, H.S. Rugo, J.T. Carpenter, C. Livasy, L. Dressler, D. Chhieng, B. Singh, C. Mies, J. Rabban, Y.Y. Chen, D. Giri, A. Au, N. Hylton, and The I-SPY 1 TRIAL Investigators Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Breast Cancer Res Treat 132 2012 1049 1062
12. M.E. Straver, A.M. Glas, J. Hannemann, J. Wesseling, M.J. van de Vijver, E.J. Rutgers, M.J. Vrancken Peeters, H. van Tinteren, L.J. van't Veer, and S. Rodenhuis The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer Breast Cancer Res Treat 119 2010 551 558
13. T. Iwamoto, J.S. Lee, G. Bianchini, R.E. Hubbard, E. Young, J. Matsuoka, S.B. Kim, W.F. Symmans, G.N. Hortobagyi, and L. Pusztai First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations Breast Cancer Res Treat 130 2011 155 164
14. S. Glück, F. de Snoo, J. Peeters, L. Stork-Sloots, and G. Somlo Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy Breast Cancer Res Treat 139 2013 759 767
15. M. Knauer, S. Mook, E.J. Rutgers, R.A. Bender, M. Hauptmann, M.J. van de Vijver, R.H. Koornstra, J.M. Bueno-de-Mesquita, S.C. Linn, and L.J. van 't Veer The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer Breast Cancer Res Treat 120 2010 655 661
16. C.A. Drukker, J.M. Bueno-de-Mesquita, V.P. Retèl, W.H. van Harten, H. van Tinteren, J. Wesseling, R.M. Roumen, M. Knauer, L.J. van 't Veer, G.S. Sonke, E.J. Rutgers, M.J. van de Vijver, and S.C. Linn A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study Int J Cancer 133 2013 929 936
17. A.M. Glas, A. Floore, L.J. Delahaye, A.T. Witteveen, R.C. Pover, N. Bakx, J.S. Lahti-Domenici, T.J. Bruinsma, M.O. Warmoes, R. Bernards, L.F. Wessels, and L.J. van't Veer Converting a breast cancer microarray signature into a high-throughput diagnostic test BMC Genomics 30 2006 278
18. S. Paik, C.Y. Kim, Y.K. Song, and W.S. Kim Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer Nat Clin Pract Oncol 2 2005 246 254
19. S.M. Farragher, A. Tanney, R.D. Kennedy, and D.P. Harkin RNA expression analysis from formalin fixed paraffin embedded tissues Histochem Cell Biol 130 2008 435 445
20. B. Ward, and K. Heuermann Detection of prostate cancer biomarkers by expression microarray analysis of Transplex® WTA2-amplified FFPE tissue RNA (abstract) J Biomol Tech 21 3 Suppl 2010 S30
21. L. Turner, J.D. Heath, and N. Kurn Gene expression profiling of RNA extracted from FFPE tissues: NuGEN Technologies' whole-transcriptome amplification system Methods Mol Biol 724 2011 269 280
22. M.E. Hammond, D.F. Hayes, A.C. Wolff, P.B. Mangu, and S. Temin American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Oncol Pract 6 2010 195 197
23. L. Mittempergher, J.J. de Ronde, M. Nieuwland, R.M. Kerkhoven, I. Simon, E.J. Rutgers, L.F. Wessels, and L.J. van't Veer Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue PLoS One 6 2011 e17163
24. D.W. Tholen, A. Kallner, J.W. Kennedy, J.S. Krouwer, and K. Meier Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline, ed 2 NCCLS publication EP5A2 2004 National Committee for Clinical Laboratory Standards (NCCLS) Wayne, PA
25. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
26. F. Medeiros, C.T. Rigl, G.G. Anderson, S.H. Becker, and K.C. Halling Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities Arch Pathol Lab Med 131 2007 1805 1816
27. G. Bussolati, L. Annaratone, E. Medico, G. D'Armento, and A. Sapino Formalin fixation at low temperature better preserves nucleic acid integrity PLoS One 6 2011 e21043
28. M. Comanescu, L. Annaratone, G. D'Armento, G. Cardos, A. Sapino, and G. Bussolati Critical steps in tissue processing in histopathology Recent Pat DNA Gene Seq 6 2012 22 32
29. S. Asioli, F. Maletta, L. Verdun di Cantogno, M.A. Satolli, M. Schena, C. Pecchioni, C. Botta, L. Chiusa, L. Molinaro, L. Conti, G. Viale, G. Ingravallo, E. Maiorano, and A. Sapino Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer Hum Pathol 43 2012 2070 2079
30. L.J.M.J. Delahaye, D. Wehkamp, A.N. Floore, R. Bernards, L.J. van't Veer, and A.M. Glas Performance characteristics of the MammaPrint® breast cancer diagnostic gene signature Per Med 10 2013 801 811
31. P. Roepman The future of diagnostic gene-expression microarrays: bridging the gap between bench and bedside Bioanalysis 2 2010 249 262
32. J.S. Parker, M. Mullins, M.C. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, J.F. Quackenbush, I.J. Stijleman, J. Palazzo, J.S. Marron, A.B. Nobel, E. Mardis, T.O. Nielsen, M.J. Ellis, C.M. Perou, and P.S. Bernard Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 2009 1160 1167